JLL Income Property Trust, an institutionally managed daily NAV REIT, has fully subscribed JLLX Ardenwood, DST. The $90 million, two-property life sciences portfolio, located in Fremont, Calif., was structured as a Delaware Statutory Trust designed to provide 1031 exchange investors the opportunity to reinvest proceeds from the sale of appreciated real estate while also deferring taxes, maintaining their allocation to real estate and enjoying the opportunity to realize long-term appreciation in a tax-efficient manner.
“We are pleased to have fully subscribed JLLX Ardenwood, DST,” said Drew Dornbusch, head of JLL Exchange. “We continue to see strong demand from 1031 exchange investors and their financial advisers, as demonstrated by the successful syndication of this $90 million offering.”
“Life science properties in the Bay Area are among the strongest performing in the medical/healthcare sector, with demand significantly outpacing supply. With a weighted ave
